✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
首页 › 产品目录 › 盐酸苯达莫司汀

盐酸苯达莫司汀

CAS 3543-75-7C16H22Cl3N3O2MW 394.7

济南圣和化工有限公司现供应医药中间体及原料药——盐酸苯达莫司汀(CAS 3543-75-7),分子式 C16H22Cl3N3O2,分子量 394.7。本页理化参数仅供参考,实际常规纯度 按批次COA提供(不公开发布),以批次 COA 及订单确认为准,支持批量采购与长期供货协议。

产品概览

CAS号3543-75-7
分子式C16H22Cl3N3O2
分子量394.7
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域医药中间体及原料药
类别医药中间体及原料药

应用领域

医药中间体及原料药

该产品的下游应用集中在医药中间体及原料药。不同客户工艺差异较大,我们支持按需提供样品与小批量试用。

包装与储存

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
运输常规化工运输
样品可协商提供
交期现货/按订单安排

供应说明:盐酸苯达莫司汀 常规包装为按订单/批次确认(不公开发布),储存时应密封置于阴凉干燥处,避免与氧化剂混放。济南圣和化工有限公司 支持国内物流发货,大货交期与运费以订单确认为准。

质量与文件

每批产品随货提供 COA(分析证书);可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

选择 济南圣和化工有限公司 的理由:产品信息透明(含 CAS、分子式、理化参数)、报价响应快(一个工作日内)、单证齐全(COA/MSS/质检资料按需提供)、支持批量与长期协议供货。如需 盐酸苯达莫司汀 以外的配套原料,也欢迎一并列出需求清单。

常见问题

盐酸苯达莫司汀 的 CAS 号是多少?

盐酸苯达莫司汀 的 CAS 号为 3543-75-7。

该产品的纯度和包装规格是什么?

常规纯度规格为 按批次COA提供(不公开发布),包装为 按订单/批次确认(不公开发布),随货提供 COA。

盐酸苯达莫司汀 有什么用途?

主要应用于医药中间体及原料药。

如何购买或获取报价?

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系,注明产品名称、CAS 号与需求数量,一个工作日内回复报价。供应商:济南圣和化工有限公司。

PubChem 公开数据

Description

Bendamustine Hydrochloride · CAS 3543-75-7 · C16H22Cl3N3O2. UNII 981Y8SX18M.

Identification

CAS Registry Number3543-75-7
PubChem CID77082
Molecular formulaC16H22Cl3N3O2
IUPAC name4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydrochloride
UNII (FDA)981Y8SX18M

Computed Descriptors

Molecular Weight394.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count9
Exact Mass393.077760
Monoisotopic Mass393.077760
Topological Polar Surface Area58.4
Heavy Atom Count24
Formal Charge0
Complexity380

GHS Hazard Classification

Reported hazard statementsH301 (95.9%), H340 (12.2%), H350 (12.2%), H351 (87.8%), H360 (95.9%)

H301 (95.9%): Toxic if swallowed [Danger Acute toxicity, oral]

H340 (12.2%): May cause genetic defects [Danger Germ cell mutagenicity]

Documented Uses

  • Breast Feeding; Lactation; Antineoplastic Agents, Alkylating; Nitrosourea Compounds
  • Bendamustine hydrochloride is approved to treat:
  • • B-cell non-Hodgkin lymphoma (NHL) that is indolent (slow-growing) and got worse during or within 6 months after treatment with rituximab.
  • • Chronic lymphocytic leukemia (CLL).
  • Bendamustine hydrochloride is also being studied in the treatment of other types of cancer.
  • A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA,

Synonyms

Bendamustine hydrochloride; 3543-75-7; Bendamustine HCl; Treanda; Ribomustin; Bendamustin hydrochloride; Bendeka; Ribomustine; SyB L-0501; VIVIMUSTA; Levact; NSC-138783; SYBL-0501; 981Y8SX18M; DTXSID40188912; NSC138783

Frequently Asked Questions

What are the CAS number and molecular formula of Bendamustine Hydrochloride?

CAS 3543-75-7; molecular formula C16H22Cl3N3O2; molecular weight — g/mol.

What other names is Bendamustine Hydrochloride known by?

Bendamustine hydrochloride, 3543-75-7, Bendamustine HCl, Treanda, Ribomustin, Bendamustin hydrochloride.

Is Bendamustine Hydrochloride classified as hazardous?

Hazard statements reported: H301, H340, H350, H351, H360.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

获取报价

✉ info@591daili.com☎ +86-18553102138📞 WhatsApp邮件询价WhatsApp 询价

供应商:济南圣和化工有限公司

English page: Bendamustine Hydrochloride

鲁ICP备19031700号-2